General Information of Binding Target of SBP (BTS) (ID: ST00218)
BTS Name
Hypoxia-inducible factor 1-alpha
Synonyms
HIF-1-alpha; HIF1-alpha; ARNT-interacting protein; Basic-helix-loop-helix-PAS protein MOP1; Class E basic helix-loop-helix protein 78; bHLHe78; Member of PAS protein 1; PAS domain-containing protein 8
BTS Type
Protein
Gene Name
HIF1A
Organism
Homo sapiens (Human)
Function
Functions as a master transcriptional regulator of the adaptive response to hypoxia Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 Activity is enhanced by interaction with NCOA1 and/or NCOA2 Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia ; (Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent proinflammatory state In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response
UniProt ID
Q16665
UniProt Entry
HIF1A_HUMAN
PFam
PF11413 ; PF08778 ; PF00989 ; PF08447
Gene ID
3091
Sequence
MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNVSSHLDKASVM
RLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFVMVLTDDGDMIYISDNVNKYM
GLTQFELTGHSVFDFTHPCDHEEMREMLTHRNGLVKKGKEQNTQRSFFLRMKCTLTSRGR
TMNIKSATWKVLHCTGHIHVYDTNSNQPQCGYKKPPMTCLVLICEPIPHPSNIEIPLDSK
TFLSRHSLDMKFSYCDERITELMGYEPEELLGRSIYEYYHALDSDHLTKTHHDMFTKGQV
TTGQYRMLAKRGGYVWVETQATVIYNTKNSQPQCIVCVNYVVSGIIQHDLIFSLQQTECV
LKPVESSDMKMTQLFTKVESEDTSSLFDKLKKEPDALTLLAPAAGDTIISLDFGSNDTET
DDQQLEEVPLYNDVMLPSPNEKLQNINLAMSPLPTAETPKPLRSSADPALNQEVALKLEP
NPESLELSFTMPQIQDQTPSPSDGSTRQSSPEPNSPSEYCFYVDSDMVNEFKLELVEKLF
AEDTEAKNPFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSPLESSSASPESASPQSTVT
VFQQTQIQEPTANATTTTATTDELKTVTKDRMEDIKILIASPSPTHIHKETTSATSSPYR
DTQSRTASPNRAGKGVIEQTEKSHPRSPNVLSVALSQRTTVPEEELNPKILALQNAQRKR
KMEHDGSLFQAVGIGTLLQQPDDHAATTSLSWKRVKGCKSSEQNGMEQKTIILIPSDLAC
RLLGQSMDESGLPQLTSYDCEVNAPIQGSRNLLQGEELLRALDQVN
Sequence Length
826
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
Nanobody anti-HIF-1A clone 212 Research Binder Kd: 26.6 nM Adenocarcinoma of pancreas [ICD-11: 2C10.0]
SBP Info
[1]
Nanobody anti-HIF-1A M1 Research Binder Kd: 9.3 nM Adenocarcinoma of pancreas [ICD-11: 2C10.0]
SBP Info
[1]
Nanobody anti-HIF-1A M3 Research Binder Kd: 1.5 nM Adenocarcinoma of pancreas [ICD-11: 2C10.0]
SBP Info
[1]
References
1 In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1 single-domain intrabody. Biochem Biophys Res Commun. 2020 Sep 3;529(4):936-942.